S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NBY NovaBay Pharmaceuticals Inc New

0.7519

0.0193 (2.63%)

Jan 21 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals Inc New News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Friday 10 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 December 2024 (1 month ago) • Edgar (US Regulatory)

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
Thursday 19 December 2024 (1 month ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 11 December 2024 (1 month ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 9 December 2024 (1 month ago) • Edgar (US Regulatory)

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
Monday 9 December 2024 (1 month ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 26 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
Friday 22 November 2024 (2 months ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
Friday 15 November 2024 (2 months ago) • Business Wire

More NovaBay Pharmaceuticals Inc New News Articles

Kraig Biocraft Laborator... (QB)

TPT Global Tech (CE)

KULR Technology

North Bay Resources (PK)

Cann American (CE)

Code Green Apparel (PK)

Accredited Solutions (PK)

Asia Broadband (PK)

TheGlobe com (PK)

FuelCell Energy

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions